Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
, , et
18 juin 2022
À propos de cet article
Catégorie d'article: Short Communication
Publié en ligne: 18 juin 2022
Pages: 84 - 86
Reçu: 25 avr. 2022
Accepté: 10 mai 2022
DOI: https://doi.org/10.2478/afpuc-2022-0006
Mots clés
© 2022 Jan Juřica et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Juřica, Jan
Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
Masaryk Memorial Cancer InstituteBrno, Czech Republic
Faculty of Pharmacy, Department of Pharmacology and Toxicology, Masaryk UniversityBrno, Czech Republic
Goněc, Roman
Masaryk Memorial Cancer InstituteBrno, Czech Republic
Bártová, Adela
Faculty of Medicine, Department of Pharmacology, Masaryk UniversityBrno, Czech Republic
Gregorová, Jana
Faculty of Medicine, Department of Biochemistry, Masaryk UniversityBrno, Czech Republic